Barely Significant
← all excerpts

SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma.

Biomark Res · 2021 · PMC8207655 · PMID 34134766

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantp < 0.0001actually significant
We found a moderate but highly significant negative correlation between high SMAD1 expression and KEGG Apoptosis pathway inhibition across the ~ 1000 CCLE cell lines ( R = -0.1486, p < 0.0001) (Fig.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.